These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18583950)

  • 1. [Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
    Obołończyk L; Obołończyk L; Siekierska-Hellmann M; Sworczak K
    Postepy Hig Med Dosw (Online); 2007 Jun; 62():309-21. PubMed ID: 18583950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
    Obołończyk Ł; Siekierska-Hellmann M; Wiśniewski P; Lewczuk A; Berendt-Obołończyk M; Lakomy A; Michalska Z; Radowska D; Moszkowska G; Bianek-Bodzak A; Sworczak K
    Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):842-849. PubMed ID: 29039351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
    Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-induced thyroiditis during treatment of chronic hepatitis C.
    Kozielewicz D; Halota W
    Endokrynol Pol; 2012; 63(1):66-70. PubMed ID: 22378101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
    Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
    Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin--a review.
    Andrade LJ; Atta AM; D'Almeida Junior A; Paraná R
    Braz J Infect Dis; 2008 Apr; 12(2):144-8. PubMed ID: 18641852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
    Gill G; Bajwa H; Strouhal P; Buch HN
    J Med Case Rep; 2016 Sep; 10(1):253. PubMed ID: 27632981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid disease in HCV carriers undergoing antiviral therapy with interferon plus ribavirin.
    Paraná R; Cruz M; Santos-Jesus R; Ferreira K; Codes L; Cruz T
    Braz J Infect Dis; 2000 Dec; 4(6):284-90. PubMed ID: 11136525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha induced transient thyroid dysfunction in hepatitis C.
    Fernández-Díez S; Rodríguez-Agulló JL; Cascudo Rielo MJ; Navarro Angulo N; Díaz-Rubio M
    Rev Esp Enferm Dig; 2002 Mar; 94(3):159-63. PubMed ID: 12185880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.
    Rotondi M; Minelli R; Magri F; Leporati P; Romagnani P; Baroni MC; Delsignore R; Serio M; Chiovato L
    Eur J Endocrinol; 2007 Apr; 156(4):409-14. PubMed ID: 17389454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid dysfunction during interferon alpha therapy for chronic hepatitis C.
    Shen L; Bui C; Mansberg R; Nguyen D; Alam-Fotias S
    Clin Nucl Med; 2005 Aug; 30(8):546-7. PubMed ID: 16024950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
    Huang JF; Chuang WL; Dai CY; Chen SC; Lin ZY; Lee LP; Lee PL; Wang LY; Hsieh MY; Chang WY; Yu ML
    J Viral Hepat; 2006 Jun; 13(6):396-401. PubMed ID: 16842442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-associated thyroid dysfunction in anti-D-related chronic hepatitis C.
    Sachithanandan S; Clarke G; Crowe J; Fielding JF
    J Interferon Cytokine Res; 1997 Jul; 17(7):409-11. PubMed ID: 9243373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thyrotoxicosis induced by interferonotherapy of chronic hepatitis C in a woman with Hashimoto's thyroiditis].
    Kozielewicz D; Junik R; Halota W
    Pol Merkur Lekarski; 2014 Aug; 37(218):108-10. PubMed ID: 25252446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations.
    Ward DL; Bing-You RG
    Endocr Pract; 2001; 7(1):52-8. PubMed ID: 11250770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha and autoimmune thyroid disease.
    Prummel MF; Laurberg P
    Thyroid; 2003 Jun; 13(6):547-51. PubMed ID: 12930598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
    Mandac JC; Chaudhry S; Sherman KE; Tomer Y
    Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of interferon-alpha-induced thyroid dysfunction vary with ethnicity, sex, smoking status, and pretreatment thyrotropin in an international cohort of patients treated for hepatitis C.
    Mammen JS; Ghazarian SR; Rosen A; Ladenson PW
    Thyroid; 2013 Sep; 23(9):1151-8. PubMed ID: 23517287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cases of interferon-alpha and interferon-beta-induced thyroiditis.
    Nonchev BI
    Folia Med (Plovdiv); 2010; 52(3):5-12. PubMed ID: 21053668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects of alpha interferon in chronic hepatitis C.
    Dusheiko G
    Hepatology; 1997 Sep; 26(3 Suppl 1):112S-121S. PubMed ID: 9305675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.